Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition in a Phase III Randomized Trial

NCT00228124 is registered in ClinicalTrials.gov with Ontario Cancer Research Network as lead sponsor.

NCT NCT00228124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00228124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition in a Phase III Randomized Trial
Lead sponsor
Ontario Cancer Research Network
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2004
Completion date
April 30, 2008
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer